Related Experiment Video
Updated: Nov 3, 2025

08:18
Engineered Vascularized Muscle Flap
Published on: January 11, 2016
8.4K
Chronic Leg Ulcers: Are Tissue Engineering and Biomaterials Science the Solution?
Christos Kyriakidis1, Ferdinand Lali2,3, Karin Vicente Greco2,3
1Regenerative Biomaterials Group, The RAFT Institute & The Griffin Institute, Northwick Park and Saint Mark's Hospital, London HA1 3UJ, UK.
Bioengineering (Basel, Switzerland)
|June 2, 2021
Summary
This review explores scaffolds and silver dressings for chronic leg ulcers (CLUs). New tissue-engineered products are needed to improve healing outcomes for these persistent wounds.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Wound Healing Research
Background:
- Chronic leg ulcers (CLUs) are difficult-to-heal wounds causing significant patient distress and healthcare costs.
- Standard treatments for CLUs often yield poor healing outcomes, necessitating novel therapeutic approaches.
- Tissue engineering and biomaterials offer promising avenues for developing advanced wound care solutions.
Purpose of the Study:
- To review current clinical applications of scaffolds in treating CLUs.
- To discuss the structure, therapeutic effects, and clinical evidence for various scaffold types and silver dressings.
- To identify the need for and propose characteristics of future tissue-engineered products for CLUs.
Main Methods:
- Literature review and synthesis of clinical trial data on scaffolds for CLUs.
- Analysis of studies on silver dressings and emerging dermal scaffolds.
- Discussion of the properties required for effective biomaterials in CLU treatment.
Main Results:
- Various scaffolds and silver dressings are utilized clinically for CLUs, with reported benefits.
- Clinical trial data supports the use of certain skin substitutes and dressings.
- Recent advancements include new dermal scaffolds with available clinical results.
Conclusions:
- Existing scaffolds and dressings show potential but do not fully address the CLU challenge.
- There is a critical need for specifically designed tissue-engineered products for CLUs.
- Future biomaterials should possess defined properties to optimize healing and patient outcomes.

